ZL-82 / Baoling Bio - LARVOL DELTA

Phase I Clinical Study of ZL-82 Tablets (clinicaltrials.gov) - P1 | N=69 | Completed | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Jun 2024

Trial completion • Trial completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Arthritis • Inflammatory Bowel Disease • Rheumatoid Arthritis • Rheumatology

ZL-82 Double-blind Clinical Trial (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P1 trial

Study of Tolerability, Safety, and Pharmacokinetics of ZL-82 in Healthy Adult Subjects. (clinicaltrials.gov) - P1 | N=58 | Recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Arthritis • Inflammatory Bowel Disease • Rheumatoid Arthritis • Rheumatology